Skip to Content

BioLife Solutions Inc BLFS

Morningstar Rating
$17.00 −0.32 (1.85%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BLFS is trading at a 42% discount.
Price
$17.22
Fair Value
$91.90
Uncertainty
Extreme
1-Star Price
$61.50
5-Star Price
$82.66
Economic Moat
Crp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BLFS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$17.32
Day Range
$16.9617.80
52-Week Range
$8.9224.50
Bid/Ask
$16.70 / $17.82
Market Cap
$770.10 Mil
Volume/Avg
238,361 / 422,863

Key Statistics

Price/Earnings (Normalized)
Price/Sales
5.19
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
414

Comparables

Valuation

Metric
BLFS
SCLX
EMBC
Price/Earnings (Normalized)
4.22
Price/Book Value
2.27
Price/Sales
5.193.870.69
Price/Cash Flow
6.59
Price/Earnings
BLFS
SCLX
EMBC

Financial Strength

Metric
BLFS
SCLX
EMBC
Quick Ratio
1.670.151.55
Current Ratio
2.860.192.20
Interest Coverage
−35.57−106.041.59
Quick Ratio
BLFS
SCLX
EMBC

Profitability

Metric
BLFS
SCLX
EMBC
Return on Assets (Normalized)
−10.51%−106.47%12.52%
Return on Equity (Normalized)
−12.98%
Return on Invested Capital (Normalized)
−11.17%−1,960.39%30.00%
Return on Assets
BLFS
SCLX
EMBC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncWfxt$139.2 Bil
BDX
Becton Dickinson & CoVnfjhg$68.7 Bil
ALC
Alcon IncSvmbhgl$41.9 Bil
CLPBY
Coloplast A/S ADRKzzw$30.5 Bil
WST
West Pharmaceutical Services IncPzvh$29.0 Bil
RMD
ResMed IncGqxjyx$28.1 Bil
BAX
Baxter International IncJdsys$21.1 Bil
COO
The Cooper Companies IncKcckc$20.0 Bil
HOLX
Hologic IncMmqnl$17.9 Bil
TFX
Teleflex IncYtdp$10.2 Bil

Sponsor Center